Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy (Adv. Sci. 16/2022)
Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy (Adv. Sci. 16/2022)
Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy (Adv. Sci. 16/2022)
Ma, Jie (Autor:in) / Li, Wei (Autor:in) / Cao, Ruiyuan (Autor:in) / Gao, Dunqin (Autor:in) / Zhang, Qiyu (Autor:in) / Li, Xiao (Autor:in) / Li, Biyou (Autor:in) / Lv, Luye (Autor:in) / Li, Mansheng (Autor:in) / Jiang, Junyi (Autor:in)
Advanced Science ; 9
01.05.2022
1 pages
Aufsatz (Zeitschrift)
Elektronische Ressource
Englisch
Application of an iPSC‐Derived Organoid Model for Localized Scleroderma Therapy
Wiley | 2022
|Treatment of Localized and Systemic Scleroderma
British Library Conference Proceedings | 2002
|Cell‐Based Therapy for Canavan Disease Using Human iPSC‐Derived NPCs and OPCs
Wiley | 2020
|